MYCORIL

This brand name is authorized in Cyprus, Hong Kong, Malta, Singapore

Active ingredients

The drug MYCORIL contains one active pharmaceutical ingredient (API):

1 Clotrimazole UNII G07GZ97H65 - CLOTRIMAZOLE

Clotrimazole acts against fungi by inhibiting ergosterol synthesis. Inhibition of ergosterol synthesis leads to structural and functional impairment of the fungal cytoplasmic membrane. Clotrimazole has a broad antimycotic spectrum of action in vitro and in vivo, which includes dermatophytes, yeasts, moulds, etc. Read about Clotrimazole

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MYCORIL Vaginal tablet	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D01AC01	Clotrimazole	D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives
Discover more medicines within D01AC01
G01AF02	Clotrimazole	G Genito urinary system and sex hormones → G01 Gynecological antiinfectives and antiseptics → G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS → G01AF Imidazole derivatives
Discover more medicines within G01AF02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 45097, 66889, 66890
Country: MT	Medicines Authority	Identifier(s): AA084/04405, AA084/04406
Country: SG	Health Sciences Authority	Identifier(s): 06447P